article thumbnail

NICE to update endometriosis guidelines to improve diagnosis and surgical management

Pharmaceutical Technology

This marks the first update to NICE’s endometriosis guidelines since 2017, representing a huge milestone for patients and practitioners alike. In response to their request, NICE conducted a surveillance review of the 2017 guidelines to evaluate whether their recommendations align with the current research and evidence.

article thumbnail

Tackling the complex development landscape of pain medicines

European Pharmaceutical Review

There is a clear trend away from developing pharmacological therapies targeting opioid receptors” There is a clear trend away from developing pharmacological therapies targeting opioid receptors. 2017; 6(S1):1–3. Neuropathic pain in adults: pharmacological management in non-specialist settings – NCBI Bookshelf.

Medicine 102
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Novartis drops presbyopia drug acquired with Encore Vision

pharmaphorum

The eyedrop formulation of UNR844 (lipoic acid/choline ester chloride) was acquired as part of the group’s buyout of privately-held ophthalmology biotech Encore Vision for $375 million upfront in 2017, and was designed to work by restoring the elasticity of the eye’s lens that declines with age.

article thumbnail

FDA suggests ways to curb constraints with rare disease gene therapy trials

Pharmaceutical Technology

Since the first approval in 2017, the FDA’s Office of Tissue and Advanced Therapies (OTAT) has approved 27 cell and gene therapies. One such example is Hemgenix (etranacogene dezaparvovec), the first gene therapy to treat adults with haemophilia B, which was approved in November.

FDA 105
article thumbnail

Recurrent drug shortages signal onerous outlook for cardiovascular care

Pharmaceutical Technology

According to some estimates, between 2017 and 2047, the number of individuals living with stroke will increase by 27% in the EU. But these substitutions do not come without complications, as these drugs can vary in their pharmacologic properties, states Page. Also, substitution can lead to further shortages, he adds.

Medicine 111
article thumbnail

Regenerative potential: cell?based therapies for heart failure

European Pharmaceutical Review

Pharmacological therapies mainly address symptoms and unfortunately a significant number of patients do not respond adequately, progressing to congestive heart failure and eventually needing a heart transplant. Frontiers in Pharmacology. Nature Publishing Group; 2017 [Cited 2023Mar]. 1 Furthermore, there are 63.3 BMC Cancer.

article thumbnail

Understanding a rare disease through the lens of real world and prevalence data

Clarivate

9; 9/2017; p447; DOI:10.1016/j.je.2017.02.001 Frontiers in Pharmacology; 13:1089033; DOI: 10.3389/fphar.2022.1089033 .” Graefe’s Archive for Clinical and Experimental Ophthalmology; V.259; 9; 9/2021; p2461; DOI:10.1007/s00417-020-04993-1 [2] Ueda K et al. ” Journal of Epidemiology; V.27; ” Cureus; V.12;